Cara Therapeutics Inc

NASDAQ:CARA   3:59:53 PM EDT
13.20
+0.32 (+2.48%)
Products

Vifor Pharma And Cara Therapeutics Announce U.S. FDA Acceptance Of NDA For Korsuva Injection

Published: 03/08/2021 06:08 GMT
Cara Therapeutics Inc (CARA) - Vifor Pharma and Cara Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for Korsuva™* Injection in Hemodialysis Patients With Moderate-to-severe Pruritus.